89Strontium-chloride (89Sr) is used to relieve bone pain in prostate cancer patients. Areas of bone with metastases contain rapidly dividing cells in comparison to healthy bone and tissue. The 89Sr localises selectively within these areas of bone.
It is administered as an injection and delivered to the site where it is needed. The treatment takes effect over a couple of weeks. Pain relief can last from three to six months, although patient responses do vary. You will be treated as an out-patient in Nuclear Medicine by the member of Nuclear Medicine Physics team